Moreover, the 36-month beta value for GNLX is -0.36. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for GNLX is 32.74M and currently, short sellers hold a 6.62% of that float. On May 14, 2025, GNLX’s average trading volume was 186.26K shares.
GNLX) stock’s latest price update
The stock price of Genelux Corp (NASDAQ: GNLX) has dropped by -10.79 compared to previous close of 2.78. Despite this, the company has seen a gain of 6.44% in its stock price over the last five trading days. globenewswire.com reported 2025-05-06 that WESTLAKE VILLAGE, Calif., May 06, 2025 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the first quarter of 2025 and provided general business updates.
GNLX’s Market Performance
Genelux Corp (GNLX) has experienced a 6.44% rise in stock performance for the past week, with a 0.81% rise in the past month, and a -56.18% drop in the past quarter. The volatility ratio for the week is 17.72%, and the volatility levels for the past 30 days are at 11.82% for GNLX. The simple moving average for the past 20 days is -8.21% for GNLX’s stock, with a -13.63% simple moving average for the past 200 days.
Analysts’ Opinion of GNLX
Many brokerage firms have already submitted their reports for GNLX stocks, with Guggenheim repeating the rating for GNLX by listing it as a “Buy.” The predicted price for GNLX in the upcoming period, according to Guggenheim is $8 based on the research report published on October 29, 2024 of the previous year 2024.
ROTH MKM, on the other hand, stated in their research note that they expect to see GNLX reach a price target of $10. The rating they have provided for GNLX stocks is “Buy” according to the report published on August 28th, 2024.
H.C. Wainwright gave a rating of “Buy” to GNLX, setting the target price at $35 in the report published on November 27th of the previous year.
GNLX Trading at -17.35% from the 50-Day Moving Average
After a stumble in the market that brought GNLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -57.86% of loss for the given period.
Volatility was left at 11.82%, however, over the last 30 days, the volatility rate increased by 17.72%, as shares surge +2.48% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -32.05% lower at present.
During the last 5 trading sessions, GNLX rose by +6.44%, which changed the moving average for the period of 200-days by +29.17% in comparison to the 20-day moving average, which settled at $2.70. In addition, Genelux Corp saw 5.08% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GNLX starting from Ryder Sean, who sale 4,475 shares at the price of $2.92 back on May 12 ’25. After this action, Ryder Sean now owns 47,621 shares of Genelux Corp, valued at $13,067 using the latest closing price.
Zindrick Thomas, the President and CEO of Genelux Corp, sale 10,764 shares at $2.92 during a trade that took place back on May 12 ’25, which means that Zindrick Thomas is holding 191,447 shares at $31,431 based on the most recent closing price.
Stock Fundamentals for GNLX
Current profitability levels for the company are sitting at:
- -69.46 for the present operating margin
- -0.45 for the gross margin
The net margin for Genelux Corp stands at -65.29. The total capital return value is set at -1.0. Equity return is now at value -131.36, with -92.71 for asset returns.
Based on Genelux Corp (GNLX), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -12.48.
Currently, EBITDA for the company is -28.97 million with net debt to EBITDA at 0.5. When we switch over and look at the enterprise to sales, we see a ratio of 175.14. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.67.
Conclusion
To wrap up, the performance of Genelux Corp (GNLX) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
